Folic Acid-Targeted Mixed Pluronic Micelles for Delivery of Triptolide
2024

Folic Acid-Targeted Mixed Pluronic Micelles for Delivery of Triptolide

Sample size: 18 publication Evidence: moderate

Author Information

Author(s): Yin Meizhen, Zhang Xinying, Zhang Tongguang, Bao Zhiqiang, He Zhihui

Primary Institution: Medical College, Inner Mongolia Minzu University, Tongliao, China

Hypothesis

The study aimed to explore an ideal delivery system for triptolide using folate-modified mixed pluronic micelles.

Conclusion

FA–F-127/F-68–TPL shows strong cytotoxicity against liver cancer cells and significantly inhibits the growth of liver cancer xenografts.

Supporting Evidence

  • FA–F-127/F-68–TPL significantly reduced HepG2 cell viability.
  • FA–F-127/F-68–TPL showed enhanced cytotoxicity compared to bare TPL.
  • FA–F-127/F-68–TPL effectively targeted tumor tissue in a nude mouse model.
  • Smaller particle size of FA–F-127/F-68–TPL allows better penetration into tumors.

Takeaway

Researchers created tiny balls that can carry a medicine called triptolide to fight liver cancer, and they found that these balls work really well at getting the medicine to the cancer cells.

Methodology

The study used thin-film hydration to prepare drug-loaded micelles and tested their effectiveness in vitro and in vivo.

Limitations

The study noted challenges in targeting tumors with an insignificant EPR effect.

Participant Demographics

Male BALB/c-nu 5–6-week-old nude mice were used for the in vivo experiments.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.3390/polym16243485

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication